Knowledge,attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population

• Cervical cancer mortality rates in Egypt are also relatively high, with an age-standardized mortality rate of around 3.2 per 100,000 women.

Risk Factors and Epidemiology:

• The primary risk factor for cervical cancer in Egypt is persistent infection with high-risk strains of the human papillomavirus (HPV), particularly HPV 16 and 18.
• Other risk factors include early age of first sexual intercourse, multiple sexual partners, high parity, smoking, and lack of regular cervical cancer screening.
• Socioeconomic factors, such as low education levels and limited access to healthcare services, also contribute to the cervical cancer burden in Egypt.
• Cervical cancer disproportionately affects women in rural and disadvantaged areas, where screening and preventive services are less accessible.

Screening and Prevention Efforts:

• Cervical cancer screening through Pap smears or HPV testing is the primary method for early detection and prevention of the disease.
• However, cervical cancer screening coverage in Egypt remains low, with only around 10-20% of eligible women being regularly screened.
• The Egyptian Ministry of Health and Population has implemented various initiatives to improve cervical cancer screening and awareness, but more efforts are needed to reach underserved populations.
• The introduction and widespread uptake of the HPV vaccine could significantly reduce the burden of cervical cancer in Egypt, but vaccine coverage remains suboptimal.
• Cervical cancer is a significant public health concern, as it is the fourth most common cancer in women worldwide, with a high mortality rate, especially in developing countries.
• Early detection through regular cervical cancer screening (e.g., Pap smears) and treatment of precancerous lesions can effectively prevent the development of cervical cancer.